The rest of the parameters that were examined did not exhibit such significance with the SLEDAI-2K scores, i.e., ethnicity (p = 0.614), history of autoimmune disease (p = 0.191), immunosuppressant intake (p = 0.441), ANA-positive (p = 0.651), anti-dsDNA-positive (p = 0.324), CRP status (p > 0.999), serum IL-17 levels (p = 0.508), serum IL-23 levels (p = 0.466), and the proportion of IL-17RA+ Th cells (p = 0.743) (Table 2). Here, IL17A is linked to autoimmune disease.